Skip to content

Efficacy and Safety of Additive Manufacturing Personalized Titanium Mesh in Guided Bone Regeneration

Efficacy and Safety of Additive Manufacturing Personalized Titanium Mesh in Guided Bone Regeneration: a Randomized, Single-blind, Positive-controlled Prospective Study

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06692244
Enrollment
142
Registered
2024-11-18
Start date
2024-11-30
Completion date
2028-12-31
Last updated
2025-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alveolar Bone Atrophy, Guided Bone Regeneration

Brief summary

This goal of this single-blind, simple randomized, positive-controlled prospective study is to evaluate the effects of additive-manufactured personalized titanium mesh and traditional titanium mesh in guided bone regeneration for large alveolar bone defects. The study will assess the short-term and long-term efficacy, safety, and incidence of complications of the additive-manufactured personalized titanium mesh, along with an analysis of risk factors. Participants will be followed up for two years after surgery with free-of-charge clinical and radiographic examinations.

Interventions

PROCEDUREGuided Bone Regeneration Surgery Using Additive-Manufactured Personalized Titanium Mesh

Preoperative CBCT datas of participants are obtained to design and manufacture personalized titanium meshes.Use additive-manufactured personalized titanium meshes for guided bone regeneration.In the bone grafting surgery, the additive-manufactured personalized titanium mesh is used to secure the bone substitutes, with fixation screws used to secure the titanium mesh.

PROCEDUREGuided Bone Regeneration Surgery Using Prefabricated Titanium Mesh

In bone grafting surgery, prefabricated titanium mesh is used to fix the bone substitutes, and fixation screws are used to secure the titanium mesh.

Sponsors

Southern Medical University, China
CollaboratorOTHER
Meizhou People's Hospital
CollaboratorOTHER
Shenzhen Stomatology Hospital
CollaboratorUNKNOWN
Guangzhou Medical University
CollaboratorOTHER
Hospital of Stomatology, Sun Yat-Sen University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

1. Patients missing single or multiple teeth with moderate to severe bone defects in the edentulous area requiring complex guided bone regeneration. (Moderate bone defects: bone loss with residual alveolar ridge width between 1 mm and 3 mm; severe bone defects: bone loss with residual alveolar ridge width ≤ 1 mm.) 2. The edge of the edentulous area within 1 mm is alveolar bone, with no adjacent tooth roots or nerve canals, ensuring complete retention of the personalized titanium mesh edge. The apical edge of the edentulous area within 2 mm is alveolar bone, with no nerve canals, ensuring that retention screws for the personalized titanium mesh can be designed in this area. 3. The patient and/or his/her guardian agrees to participate in this trial and signs the informed consent form.

Exclusion criteria

1. Patients with edentulism. 2. Patients with mild bone defects (residual alveolar ridge width greater than 3 mm). 3. Presence of acute or chronic infection in the surgical area. 4. Presence of acute or chronic infection in the teeth adjacent to the edentulous area. 5. Participation in similar trials or other interventional clinical trials within 30 days prior to signing the informed consent form. 6. History of metal allergies, severe allergy history, or severe immune deficiency. 7. Uncontrolled metabolic diseases, such as Type 1 diabetes or Type 2 diabetes (HbA1c ≥ 7% or fasting blood glucose ≥ 7 mmol/L despite medication control), severe liver or kidney dysfunction (ALT, AST \> 2 times the upper limit of normal, serum creatinine above the upper limit of normal). 8. Long-term use of steroid medications. 9. History of drug abuse or alcoholism. 10. Pregnant or breastfeeding women. 11. Poor compliance. 12. Other conditions deemed unsuitable for participation by the investigator.

Design outcomes

Primary

MeasureTime frameDescription
Osteogenesis efficiency6 months after surgeryBased on the oral CBCT imaging data, bone volume is reconstructed for preoperative, the day of surgery, and six months after surgery. Bone volume changes are assessed by using mimics as the bone resorption rate. The bone formation effectiveness is evaluated based on the bone resorption rate.

Secondary

MeasureTime frameDescription
Incidence of titanium mesh exposure14 days, 1 month, 6 months, 1 year, and 2 years after surgeryRecord and observe the exposure of the titanium mesh during the healing process.

Countries

China

Contacts

Primary ContactJiayun Xu
hsujiayun@outlook.com+86 135 3354 6195
Backup ContactJinming Wang
wjinm@mail.sysu.edu.cn+86 135 3545 8675

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026